AR033424A1 - Composiciones farmaceuticas - Google Patents

Composiciones farmaceuticas

Info

Publication number
AR033424A1
AR033424A1 ARP020100690A ARP020100690A AR033424A1 AR 033424 A1 AR033424 A1 AR 033424A1 AR P020100690 A ARP020100690 A AR P020100690A AR P020100690 A ARP020100690 A AR P020100690A AR 033424 A1 AR033424 A1 AR 033424A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
compositions
pravastatin
mammals
mammal
Prior art date
Application number
ARP020100690A
Other languages
English (en)
Inventor
Rene Belder
Mark E Mcgovern
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AR033424A1 publication Critical patent/AR033424A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Métodos y composiciones farmacéuticas para reducir los niveles de colesterol LDL en mamíferos que comprende la administracion de una cantidad terapéuticamente efectiva de más de 40 mg una vez al día de pravastatina, o una sal o éster farmacéuticamente aceptable de la misma a un mamífero que necesita de dicho tratamiento.
ARP020100690A 2001-02-27 2002-02-27 Composiciones farmaceuticas AR033424A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/794,449 US20020183383A1 (en) 2001-02-27 2001-02-27 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AR033424A1 true AR033424A1 (es) 2003-12-17

Family

ID=25162649

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100690A AR033424A1 (es) 2001-02-27 2002-02-27 Composiciones farmaceuticas

Country Status (9)

Country Link
US (2) US20020183383A1 (es)
EP (1) EP1377277B1 (es)
AR (1) AR033424A1 (es)
AT (1) ATE403423T1 (es)
DE (1) DE60228064D1 (es)
ES (1) ES2309148T3 (es)
PE (1) PE20020893A1 (es)
UY (1) UY27187A1 (es)
WO (1) WO2002067911A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
US5622985A (en) * 1990-06-11 1997-04-22 Bristol-Myers Squibb Company Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
GB2253787A (en) * 1991-01-28 1992-09-23 Merck & Co Inc Hypercholesterolemia treating compositions
US6369103B1 (en) * 1994-01-18 2002-04-09 Bristol-Myers Squibb Company Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
IL149422A0 (en) * 1999-11-03 2002-11-10 Smith Howard J & Ass Pty Ltd Oral pharmaceutical compositions for liver therapy

Also Published As

Publication number Publication date
EP1377277B1 (en) 2008-08-06
EP1377277A1 (en) 2004-01-07
US20030125379A1 (en) 2003-07-03
DE60228064D1 (de) 2008-09-18
WO2002067911A1 (en) 2002-09-06
UY27187A1 (es) 2002-09-30
PE20020893A1 (es) 2002-10-25
ATE403423T1 (de) 2008-08-15
ES2309148T3 (es) 2008-12-16
US20020183383A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
BG104680A (en) Celecoxib compositions
BR0013704A (pt) Uso de inibidores do sistema renina-angiotensina na prevenção de casos cardiovasculares
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
BR0008059A (pt) Composições de valdecoxib
MA28102A1 (fr) Formulations pharmaceutiques, methodes et schemas d'administration pour le traitement et la prevention des syndromes coronariens aigus
CO5160320A1 (es) Metodos y composiciones para la prevencion de tolerancia a medicamentos das.
ES2721899T3 (es) Composiciones farmacéuticas que comprenden fentanilo para su administración intranasal
ECSP003807A (es) Composiciones valdecoxib
BR0214075A (pt) Dosagem unitária que compreende um análogo de prostaglandina para tratar constipação
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
DK1035859T3 (da) Anvendelse af phospholipidkomplekser fra ekstrakter af Vitis vinifera som anti-atherosklerotiske midler
ES2194933T3 (es) Inhibidores de la agregacion plaquetaria.
CO5200850A1 (es) Composicion farmaceutica para profilaxis y tratamiento de sintomas asociados con la gripa, influenza y enfermedades similares y procedimiento para su aplicacion
CO5210869A1 (es) Una combinacion sinergetica: gabapentina y pregabalina
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
AR033424A1 (es) Composiciones farmaceuticas
ATE350064T1 (de) Pharmazeutische zusammensetzungen von rapamycines
DOP2002000347A (es) Composiciones farmaceuticas.
CO5580773A2 (es) Rosuvastatina en estados pre dementes
BR9809376A (pt) Pregnan-3-ol-20-onas
ECSP034513A (es) Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina
BR0012502A (pt) Inibidores da expressão do gene para interleucina 5
NO974956L (no) Terapeutisk sammensetning for artritis
BR0012121A (pt) Derivado de aminotetralina para terapia de doenças cardiovasculares
AR010344A1 (es) Uso de equilenina o una sal farmaceuticamente aceptable del ester de equilenina-3-sulfato para la manufactura de un medicamento util para inhibir otratar patologias inducidas por los radicales libres y composiciones farmaceuticas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal